Thus, our results indicate that iPLA2β-mediated lipid detoxification is critically involved in suppressing p53-mediated ferroptosis and tumor suppression and suggest that iPLA2β is a promising target for activating ferroptosis in human cancers. This evidence concerns the gene TP53 and cancer.